NOV 25, 2015 4:15 PM PST

The Flu Probably Won't Kill You, But This Side Effect Might

WRITTEN BY: Kara Marker
The H1N1 influenza caused a massive panic in 2009, and scientists may have an answer for why this strain of flu is so much deadlier. A gene mutation making people susceptible to a "deadly hyperinflammatory disorder" was investigated in a study conducted by scientists from Cincinnati Children's Hospital Medical Center, and the findings were recently published in The Journal of Infectious Diseases.

Everybody needs cytokines, macrophages, and T cells to fight off infections, but a little bit of inflammation goes a long way. In a study of 16 patients who died while infected with H1N1, 44 percent of cases were connected to a condition called reactive hemophagocytic lymphohistiocytosis (rHLH). Tissue samples were taken from these patients, and full genetic screening was performed on the samples. HLH gene mutations render people susceptible to developing severe inflammatory reactions when infected with a pathogen. 

The more a pathogen naturally triggers inflammation as the body responds to fight off infection, the more likely someone with this gene mutation is to experience deadly inflammation. H1N1 stimulates more inflammation than other strains of the flu, so this could explain why the pandemic in 2009 was so deadly. 

"H1N1 has become part of the viral mix for the annual flu season and preventative vaccine", Cincinnati scientists said.

Patients experiencing the effects of this hyperinflammatory condition have overwhelming inflammation damages to their vital internal organs, causing death. A part of this reaction comes from macrophage activation syndrome (MAS), a complication normally associated with autoimmune disease that causes "uncontrolled proliferation of T lymphocytes and well-differentiated macrophages" (Medscape). 81 percent of the tissue samples from the study were associated with MAS. 

The results of this study cause scientists to think about screening options for this genetic mutation, especially in children. Another option to be investigated is immunosuppressive therapy. The right balance must be met for this treatment to be effective, enough for lethal hyperinflammation to be stopped, but not too much to totally stop inflammation needed to ward off infection. 

Watch the following video to learn more about HLH.
Source: EurekAlert


 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 18, 2021
Drug Discovery & Development
COVID-19 Antibiotic No More Effective than Placebo
JUL 18, 2021
COVID-19 Antibiotic No More Effective than Placebo
Azithromycin, a broad-spectrum antibiotic commonly used to prevent symptoms of COVID-19 in non-hospitalized patients, do ...
JUL 19, 2021
Health & Medicine
The Pandemic and Fewer Asthma Attacks?
JUL 19, 2021
The Pandemic and Fewer Asthma Attacks?
Asthma sufferers: Quarantine during the pandemic may have not only helped you avoid COVID but more asthma attacks as wel ...
JUL 27, 2021
Immunology
Rethinking Immune Responses Involved in Skin Hypersensitivity
JUL 27, 2021
Rethinking Immune Responses Involved in Skin Hypersensitivity
A study by immunologists at the University of Copenhagen has revealed a never-before-seen immune pathway invol ...
AUG 18, 2021
Health & Medicine
Brain-Gut Connection in Brain Disorders Potentially Explained
AUG 18, 2021
Brain-Gut Connection in Brain Disorders Potentially Explained
Gut microbes are believed to influence brain disorders, potentially through the vagus nerve, as seen in experimental and ...
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
Loading Comments...